Russell Investments Group Ltd. Raises Holdings in Encompass Health Co. (NYSE:EHC)

Russell Investments Group Ltd. grew its position in shares of Encompass Health Co. (NYSE:EHC) by 1.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 101,363 shares of the company’s stock after buying an additional 1,927 shares during the quarter. Russell Investments Group Ltd.’s holdings in Encompass Health were worth $7,661,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Berman Capital Advisors LLC grew its holdings in shares of Encompass Health by 75.1% during the second quarter. Berman Capital Advisors LLC now owns 788 shares of the company’s stock worth $61,000 after purchasing an additional 338 shares during the last quarter. Maverick Capital Ltd. acquired a new stake in shares of Encompass Health during the second quarter worth about $73,000. Rockefeller Capital Management L.P. boosted its stake in shares of Encompass Health by 377.1% during the second quarter. Rockefeller Capital Management L.P. now owns 1,002 shares of the company’s stock worth $77,000 after buying an additional 792 shares during the period. Private Capital Group LLC boosted its stake in shares of Encompass Health by 23.4% during the third quarter. Private Capital Group LLC now owns 1,308 shares of the company’s stock worth $99,000 after buying an additional 248 shares during the period. Finally, Fifth Third Bancorp boosted its stake in shares of Encompass Health by 265.2% during the third quarter. Fifth Third Bancorp now owns 1,366 shares of the company’s stock worth $103,000 after buying an additional 992 shares during the period. 90.21% of the stock is currently owned by institutional investors.

Shares of NYSE:EHC opened at $65.86 on Friday. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 1.39. The company has a market cap of $6.55 billion, a P/E ratio of 16.22, a PEG ratio of 0.74 and a beta of 1.02. Encompass Health Co. has a 52 week low of $56.31 and a 52 week high of $89.68. The company has a 50-day moving average price of $64.69 and a 200 day moving average price of $64.58.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, October 27th. The company reported $1.03 EPS for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.03). Encompass Health had a net margin of 8.10% and a return on equity of 19.87%. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.31 billion. During the same quarter in the previous year, the business earned $0.78 EPS. Encompass Health’s revenue for the quarter was up 9.4% on a year-over-year basis. Analysts expect that Encompass Health Co. will post 4.31 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 18th. Stockholders of record on Monday, January 3rd will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, December 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.70%. Encompass Health’s payout ratio is 27.59%.

Several brokerages have recently weighed in on EHC. Mizuho decreased their target price on shares of Encompass Health from $94.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, November 3rd. Zacks Investment Research downgraded shares of Encompass Health from a “buy” rating to a “hold” rating and set a $67.00 target price for the company. in a research note on Tuesday, November 2nd. UBS Group began coverage on shares of Encompass Health in a research note on Thursday, September 23rd. They set a “buy” rating and a $98.00 target price for the company. Truist Securities decreased their target price on shares of Encompass Health from $100.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 13th. Finally, Truist decreased their target price on shares of Encompass Health from $100.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 13th. One investment analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $88.30.

Encompass Health Profile

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Further Reading: Total Return

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.